TriSalus Life Sciences, Inc. (TLSI) Net margin 2022–2025
TriSalus Life Sciences, Inc. (TLSI) net profit margin by fiscal year — reported net income divided by reported revenue.
-86.9%FY2025 · since FY2022: -380.6% → -86.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -86.9% | +15.2 pp |
| FY2024 | -102.1% | +218.6 pp |
| FY2023 | -320.7% | +59.9 pp |
| FY2022 | -380.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →